We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Evidence indicates risks outweigh benefits.
Enforcement officers from the Medicines and Healthcare products Regulatory Agency (MHRA) have seized 23,000 doses of potentially dangerous slimming pills, with an estimated value of £30,000, during a raid on an address in Waterlooville, Hampshire.
MHRA strikes massive blow to organised criminal gang in world’s biggest illegal weight loss jabs raid.
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40mg chewable tablets.
Summary of the latest safety advice for medicines and medical device users
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).